Platelet, Fibrinolytic and Other Coagulation Abnormalities in Newly-Diagnosed Patients with Chronic Thromboembolic Pulmonary Hypertension
The pathophysiological background of chronic thromboembolic pulmonary hypertension (CTEPH) has not been fully elucidated. Evidence suggests that abnormal platelet function and ineffective fibrinolysis may play a key role in the development of the disease. The purpose of this study was to evaluate pl...
Main Authors: | Eleni Vrigkou, Argirios Tsantes, Dimitrios Konstantonis, Evdoxia Rapti, Eirini Maratou, Athanasios Pappas, Panagiotis Halvatsiotis, Iraklis Tsangaris |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-05-01
|
Series: | Diagnostics |
Subjects: | |
Online Access: | https://www.mdpi.com/2075-4418/12/5/1238 |
Similar Items
-
Coagulation Profiles of Pulmonary Arterial Hypertension Patients, Assessed by Non-Conventional Hemostatic Tests and Markers of Platelet Activation and Endothelial Dysfunction
by: Eleni Vrigkou, et al.
Published: (2020-09-01) -
Perioperative Coagulopathy in Patients with Normal Preoperative Coagulation Screen: A Couple of Coagulopathic Clinical Case Conundrums
by: Joseph N. Monteiro, et al.
Published: (2020-06-01) -
Association of Fibrinolytic Potential and Risk of Mortality in Cancer Patients
by: Gabriele Silva Souza Gois, et al.
Published: (2023-09-01) -
Carboxypeptidase U (CPU, TAFIa, CPB2) in Thromboembolic Disease: What Do We Know Three Decades after Its Discovery?
by: Karen Claesen, et al.
Published: (2021-01-01) -
Global coagulation assays in patients with diabetes mellitus
by: Hui Yin Lim, et al.
Published: (2021-10-01)